Cantargia AB (CHIX:CANTAS) Operating Margin %: -7,261.81% (As of Mar. 2026)


CHIX:CANTAS Cantargia AB CHIX:CANTAS
37 GF Score
Price kr4.17
! 2 Warning Signs
View Full Analysis

What is Cantargia AB Operating Margin %?

Cantargia AB CHIX:CANTAS 37 Operating Margin % is -7,261.81% as of Mar. 2026. GuruFocus rates CHIX:CANTAS with a GF Score™ of 37/100. The stock has 2 warning signs investors should review. Among 944 Biotechnology companies, Cantargia AB ranks better than 98.09% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Cantargia AB's Operating Income for the three months ended in Mar. 2026 was kr-36.9 Mil. Cantargia AB's Revenue for the three months ended in Mar. 2026 was kr0.5 Mil. Therefore, Cantargia AB's Operating Margin % for the quarter that ended in Mar. 2026 was -7,261.81%.

The historical rank and industry rank for Cantargia AB's Operating Margin % or its related term are showing as below:

CHIX:CANTAs' s Operating Margin % Range Over the Past 10 Years
Min: 48.75   Med: 48.75   Max: 51.15
Current: 51.15


CHIX:CANTAs's Operating Margin % is ranked better than
98.09% of 944 companies
in the Biotechnology industry
Industry Median: -86.83 vs CHIX:CANTAs: 51.15

Cantargia AB's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Cantargia AB's Operating Income for the three months ended in Mar. 2026 was kr-36.9 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was kr162.2 Mil.


Cantargia AB  (CHIX:CANTAs) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Cantargia AB Operating Margin % Related Terms


Cantargia AB Operating Margin % Historical Data

* Premium members only.

The historical data trend for Cantargia AB's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantargia AB Operating Margin % Chart

Cantargia AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 48.75

Cantargia AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 86.50 -354.14 -7,261.81

CHIX:CANTAS vs VRTX, REGN, ALNY: Operating Margin % Comparison

For the Biotechnology subindustry, Cantargia AB's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantargia AB Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cantargia AB's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Cantargia AB's Operating Margin % falls into.


CHIX:CANTAS
37GF Score
Cantargia AB CHIX:CANTAS
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cantargia AB Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Cantargia AB's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=154.388 / 316.702
=48.75 %

Cantargia AB's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=-36.89 / 0.508
=-7,261.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -7,261.81% mean?
Cantargia AB (CHIX:CANTAS) has a Operating Margin % of -7,261.81% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Cantargia AB and its competitors. Over the past decade, Cantargia AB's Operating Margin % has ranged from 48.75 to 51.15. According to the industry distribution chart, Cantargia AB ranks #18 out of 944 companies in the Biotechnology industry, placing it in the top 1.9%.
Is Cantargia AB's Operating Margin % too high?
Cantargia AB's current Operating Margin % is -7,261.81%. Over the past 10 years, this metric has ranged from a low of 48.75 to a high of 51.15. Based on the distribution chart, Cantargia AB ranks #18 out of 944 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Cantargia AB has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Cantargia AB's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Cantargia AB ranks #18 out of 944 companies for Operating Margin %. This places Cantargia AB in the top 2% of its industry — outperforming the majority of peers. Historically, Cantargia AB's own Operating Margin % has ranged from 48.75 to 51.15 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Cantargia AB and its competitors. Cantargia AB's current Operating Margin % is -7,261.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantargia AB stock overvalued right now?
Cantargia AB (CHIX:CANTAS) has a current Operating Margin % of -7,261.81%. The current Operating Margin % is -7,261.81%. Cantargia AB's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Cantargia AB (CHIX:CANTAS), the current Operating Margin % is -7,261.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantargia AB Business Description

Other Exchanges CANTA:Sweden7V3:Germany
Address Scheelevagen 27, Lund, SWE, 223 63
Cantargia AB is a Swedish biotech company that develops targeted antibody-based drugs for cancer as well as autoimmune and inflammatory diseases. It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's development programme includes the candidate drugs nadunolimab (CAN04) and CAN10, both in the clinical development stage, which were latter acquired by Otsuka Pharmaceutical in 2025. In addition, the company is also developing a a pre-clinical project CAN14, derived from antibody platform CANxx. Geographically, the company's revenues have been generated in the markets of Japan and United States.
37GF Score

Get the complete analysis for CHIX:CANTAS

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr4.17
Price